| Document |
Document Title |
|
WO/2023/229365A1 |
The present invention relates to a novel skin-derived stain, a lysate thereof, a culture solution thereof, an extract from the culture solution, and a use thereof same for improving skin conditions. With the effect of improving skin cond...
|
|
WO/2023/228969A1 |
The purpose of the present invention is to establish a novel gene transfer system for easily achieving the expression of a heterologous protein and the production of a specific metabolite in a filamentous fungus. A filamentous fungus in ...
|
|
WO/2023/228576A1 |
The device for culturing a photosynthetic organism of the present invention is provided with a culture tank for housing a liquid culture medium containing the photosynthetic organism and a liquid dispersion unit formed inside the culture...
|
|
WO/2023/229394A1 |
The present invention relates to: a novel Lactobacillus mixture composition having the excellent effect of preventing obesity; and use thereof. More specifically, the present invention relates to: a Lactobacillus mixture composition comp...
|
|
WO/2023/227124A1 |
Provided is a skeleton for constructing an mRNA transcript. Specifically, provided is an application of a universal skeleton for constructing an mRNA transcript in mRNA preparation and/or optimization. The universal skeleton can effectiv...
|
|
WO/2023/228443A1 |
[Problem] To provide a solution that is favorable for human body and effectively destroys biofilms produced by bacteria, etc., and attached to a substrate, and a method for producing the same. [Solution] A solution for destroying a biofi...
|
|
WO/2023/227905A1 |
The invention relates to a method for sequestering carbon dioxide from the atmosphere, wherein the method comprises culturing diazotrophic phytoplankton and/or diatom-diazotroph assemblages (DDAs) in land-based mariculture under oligotro...
|
|
WO/2023/226873A1 |
Provided are a recombinant BoNT/A and a preparation method thereof. The recombinant BoNT/A is a BoNT/A mutant, the BoNT/A mutant comprising a first peptide fragment and a second peptide fragment, which are linked through an interchain di...
|
|
WO/2023/227028A1 |
The present invention provides a novel Cas effector protein, a gene editing system, and a use. The Cas effector protein is CasRfg.3 and a similar protein thereof. The CasRfg.3 protein (also known as Ca2) of the present invention has a re...
|
|
WO/2023/230318A1 |
Embodiments of the present disclosure pertains to a genetically altered bacterial strain that lacks functional versions of at least three of the following proteins: FbpA; SapM; Zmpl; DosR; FadD26; SigH; nuoG; and Eis. In some embodiments...
|
|
WO/2023/230364A1 |
A method comprises flowing a mixture comprising a water-based reaction medium and at least one microalgae into a reaction vessel, wherein the reaction medium comprises a nutrient material that is consumable by a live microalgae, bacteriu...
|
|
WO/2023/226508A1 |
The present invention relates to the technical field of microbial screening and food fermentation, and in particular, to a Saccharomyces cerevisiae strain, a method for screening same, and use thereof. The strain is Saccharomyces cerevis...
|
|
WO/2023/229263A1 |
The present invention relates to a composition for preventing, treating, or improving metabolic diseases comprising Lactobacillus plantarum NCHBL-004 strain or a culture medium thereof, and the composition not only inhibits adipocyte dif...
|
|
WO/2023/230108A1 |
The instant disclosure relates to methods which employ the detection of ADP-D-glycero-β-D- manno-heptose (ADP-heptose) in a biological sample obtained from an individual. In certain aspects, the methods comprise administering a treatmen...
|
|
WO/2023/229104A1 |
The present application relates to a mixed strain of probiotics having an immunomodulatory function and a composition comprising same. A composition comprising a mixed strain of probiotics having an immunomodulatory function as an active...
|
|
WO/2023/226507A1 |
The present invention provides a high-sugar-permeation-resistant saccharomyces cerevisiae strain and use. The saccharomyces cerevisiae strain provided in the present invention is saccharomyces cerevisiae AMCC 31195 strain, which is prese...
|
|
WO/2023/226509A1 |
Provided are a yeast strain for fast-fermenting sugar-free dough and use thereof. A saccharomyces cerevisiae AMCC31248 strain provided herein is collected in the China Center for Type Culture Collection (CCTCC), with the collection numbe...
|
|
WO/2023/228987A1 |
The present invention relates to a koji mold fermentation product of a cereal-derived material which has an arabinan concentration of 5 mg/g or less. The present invention also relates to a method for producing a koji mold fermentation p...
|
|
WO/2023/161811A9 |
Disclosed are methods and devices suitable for growing algae. In some embodiments, a device suitable for growing algae includes an algae growth-substrate assembly that comprises a pair of algae growth-substrates: an inwards-sloped substr...
|
|
WO/2023/227184A2 |
|
|
WO/2023/222575A1 |
The present invention relates to a phage-resistant lactic acid bacterium, compositions comprising the bacterium, and fermented food products obtained with the bacterium or compositions comprising the bacterium.
|
|
WO/2023/221410A1 |
The present invention provides pediococcus acidilactici, which is characterized by having the accession number of CCTCC NO: M 2022095 and being deposited in China Center for Type Culture Collection on Jan. 19, 2022. The pediococcus acidi...
|
|
WO/2023/225117A1 |
The disclosure relates to genetically modified microorganisms, for example of the Genus Paenibacillus, for the improvement of phenotypes of plants, for example nitrogen availability for plants. Included are novel strains of the microorga...
|
|
WO/2023/222098A1 |
Disclosed herein is a UV mutagenesis produced new Streptomyces spororaveus strain SC263 that exhibits an increased thermostability of the antibiotic produced, which shows antibiotic activity against bacteria and fungi. Also provided are ...
|
|
WO/2023/222505A1 |
The present invention relates to a recombinant microbial cell for producing N5-aminopentyl-N- (hydroxy)-succinamic acid of Formula I from at least one simple carbon source wherein the simple carbon source is selected from the group consi...
|
|
WO/2023/222515A1 |
The present invention relates to a recombinant microbial cell for producing at least one compound having structural Formula III from at least one simple carbon source: Formula (III) m = 1-3, wherein the simple carbon source is selected f...
|
|
WO/2023/223869A1 |
The purpose of the present invention is to provide a technology useful for the treatment or diagnosis of cancer. The present invention provides an antitumor agent comprising a purple non-sulfur bacterium isolated from a tumor. The pres...
|
|
WO/2023/221787A1 |
Disclosed are a pichia pastoris engineering strain for a recombinant type I collagen, a construction method therefor and use thereof. A gene sequence for a type I humanized collagen α1 chain mature peptide is synthesized and inserted do...
|
|
WO/2023/224372A1 |
The present invention relates to a Prevotella histicola strain useful for the prevention or treatment of sleep disorders. Prevotella histicola exhibits an increase in total sleep time, non-REM (NREM) sleep time and REM sleep time, and a ...
|
|
WO/2023/223303A1 |
The present invention provides a method to obtain unique cell lines for various applications and systems and methods for a machine learning/AI/Deep Learning software platform that supports the development and optimization of functional i...
|
|
WO/2023/224098A1 |
The present invention addresses the problem of providing a parasitic dinoflagellate which belongs to the genus Amoebophrya and which is effective for controlling a red tide produced by dinoflagellates belonging to the genus Karenia. Pr...
|
|
WO/2023/222602A1 |
The invention refers to a fumonisin-sensitive yeast, specifically Saccharomyces cerevisiae, comprising disrupted or deleted genes SNQ2, PDR12, YOR1, CKA2, LCB3, and optionally any one of VPS51, VPS52, or VPS53 and its use for detecting i...
|
|
WO/2023/224117A1 |
Provided are: a microorganism belonging to the genus Akkermansia, which has a 16S rRNA gene containing a nucleotide sequence having a homology exceeding 98.0% to the nucleotide sequence represented by SEQ ID NO: 3, etc., has NOD2 agonist...
|
|
WO/2023/223993A1 |
Provided is a novel composition for treating ringworm. This composition for treating ringworm contains at least one selected from the group consisting of a bacterial strain of Staphylococcus hominis, a bacterial strain of Staphylococcu...
|
|
WO/2023/223870A1 |
The purpose of the present invention is to provide a technique useful for the treatment or diagnosis of cancer. The present invention provides an antitumor agent including bacteria isolated from a tumor. The bacteria may be, for exampl...
|
|
WO/2023/224153A1 |
The present invention relates to: mutant microorganisms in which genes involved in the production of by-products other than 1,3-propanediol are deleted; and a method for producing 1,3-propanediol using same, wherein the mutant microorgan...
|
|
WO/2023/220796A1 |
The present invention pertains to the biotechnology field aimed at the market of soundproofing and civil engineering articles, packagings, architecture and interior design, and relates, more specifically, to a method for producing fungal...
|
|
WO/2023/224248A1 |
The present application relates to: a microorganism with weakened gluconate repressor protein activity; a method for producing L-arginine by using the microorganism of the present application; a composition for producing L-arginine, comp...
|
|
WO/2023/222075A1 |
The present invention provides a method for increasing a fermentation yield of PF1022A. By using a Rosellinia sp. strain that can produce PF1022A as a production strain, aerobic fermentation is carried out in a fermentation medium. The f...
|
|
WO/2023/221826A1 |
Provided are a gene KWE2 that regulates maize ear grain weight and yield, a protein encoding same, and an expression vector thereof. Further provided are an InDel1 marker of the gene KWE2 that regulates maize ear grain weight and yield, ...
|
|
WO/2023/222956A1 |
The present invention relates to a method for manufacturing a microbial carrier. The method according to the invention aims to produce solid carriers on which microorganisms are immobilized, said supports being intended to be used in var...
|
|
WO/2023/221892A1 |
The present invention relates to antibodies specifically binding to α-Synuclein or antigen-binding fragments thereof, a pharmaceutical composition containing the antibodies or the antigen-binding fragments thereof, a nucleic acid molecu...
|
|
WO/2023/225405A1 |
A system and method for adaptive laboratory evolution (ALE) employs density stratified layers of cell growth media within a chemostat to form an interface between the layers, creating a gradient with an increasing concentration of a stre...
|
|
WO/2023/221935A1 |
The present invention provides an antibody. The antibody can specifically bind to human CLDN18.2 and human PD-L1. The present invention further provides a nucleic acid molecule encoding the antibody, an expression vector for expressing t...
|
|
WO/2023/218450A1 |
There is provided an isolated fungus belonging to the genus Kazachstania, a composition comprising same, and methods of using same, such as for preventing or treating an infection, a disease, or both.
|
|
WO/2023/219130A1 |
[Problem] To provide a liquid culture medium for improving immunity and promoting normal immune formation, said liquid culture medium promoting human healthy immune formation and curing allergic diseases such as atopic dermatitis, and a ...
|
|
WO/2023/219188A1 |
An embodiment of the present invention provides a culture medium composition for increasing growth and metabolic rates of an acetogenic strain and a method for culturing an acetogenic strain by using same. An embodiment of the present in...
|
|
WO/2023/219437A1 |
The present invention relates to a method for producing lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT) using Corynebacterium glutamicum, and more specifically to: recombinant Corynebacterium glutamicum transformed such that, in or...
|
|
WO/2023/218408A1 |
Provided are methods of identifying bacterial strains capable of colonizing the human female genitourinary tract and compositions thereof, as well as methods of defining vaginal microbial communities and profiles.
|
|
WO/2023/219095A1 |
One aspect of the present disclosure provides a method for preserving a target substance in a target liquid. The method includes: allowing a fiber sheet to absorb the target liquid by bringing the fiber sheet into contact with the target...
|
